Your browser doesn't support javascript.
loading
Prospective observational study of surgery alone for locally advanced oral squamous cell carcinoma: a real-world study.
Ren, Zhen-Hu; Liu, Keyue; Chen, Yiming; Yang, Zhi-Min; Wu, Kun; Wu, Han-Jiang.
Afiliación
  • Ren ZH; Department of Oral and Maxillofacial surgery, Second Xiangya hospital of Central South University, No.139 Renmin Road, Changsha, 410011, Hunan, China.
  • Liu K; Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, No.639, Zhizaoju Road, Shanghai, 200011, China.
  • Chen Y; Department of Oral and Maxillofacial surgery, Second Xiangya hospital of Central South University, No.139 Renmin Road, Changsha, 410011, Hunan, China.
  • Yang ZM; Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, No.639, Zhizaoju Road, Shanghai, 200011, China.
  • Wu K; Department of Oral and Maxillofacial surgery, Second Xiangya hospital of Central South University, No.139 Renmin Road, Changsha, 410011, Hunan, China.
  • Wu HJ; Department of Oral and Maxillofacial surgery, Second Xiangya hospital of Central South University, No.139 Renmin Road, Changsha, 410011, Hunan, China. wukun1302@csu.edu.cn.
BMC Oral Health ; 24(1): 156, 2024 Jan 31.
Article en En | MEDLINE | ID: mdl-38297336
ABSTRACT

INTRODUCTION:

A prospective observational study was modified to assess the efficacy of surgery alone for the treatment of locally advanced oral squamous cell carcinoma. (LA-OSCC) MATERIALS AND

METHODS:

This prospective, single-institution, single-arm study involved 174 patients who underwent major surgery for LA-OSCC. Participating patients did not receive postoperative radiation. After initial curative treatment, patients were routinely monitored via clinical examination and imaging. The follow-up period was 3-70 months. Tumour recurrence and death were considered as the Clinical End Point in Research.

RESULTS:

The 5-year overall survival (OS), disease-free survival (DFS), and locoregional control rates for 174 patients were 66.7% (95% confidence interval [CI], 59.8 to 73.6), 66.1% (95% CI, 59.2 to 73.0), and 82.4% (95% CI, 76.5 to 88.3), respectively.

CONCLUSION:

A study of patients with LA-OSCC treated with surgery alone may have the optimal therapeutic impact for LA-OSCC, as evidenced by solid data for our next RCT trial. This conclusion still needs to be validated in higher-level RCTs.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Neoplasias de Cabeza y Cuello Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Neoplasias de Cabeza y Cuello Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article